Author:
Miró Òscar,Takagi Koji,Gayat Étienne,Gil Víctor,Llorens Pere,Martín-Sánchez Francisco J.,Jacob Javier,Herrero-Puente Pablo,Escoda Rosa,Pilar López-Díez María,Valero Amparo,Fuentes Marta,Garrido José M.,Salvo Eva,Rizzi Miguel A.,Aguirre Alfons,Travería Bécquer Lissete,Domínguez-Rodríguez Alberto,Padrosa Joan,Martínez Gemma,Arrigo Mattia,Freund Yonathan,Mebazaa Alexandre
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,General Medicine
Reference30 articles.
1. Chioncel O, Mebazaa A, Harjola VP, Coats AJ, Piepoli MF, Crespo-Leiro MG et al (2017) Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long-Term Registry. Eur J Heart Fail 19:1242–1254
2. Llorens P, Javaloyes P, Martín-Sánchez FJ, Jacob J, Herrero-Puente P, Gil V et al (2018) Time trends in characteristics, clinical course, and outcomes of 13,791 patients with acute heart failure. Clin Res Cardiol 107:897–913
3. O'Connor CM, Starling RC, Hernandez AF, Armstrong PW, Dickstein K, Hasselblad V et al (2011) Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med 365:32–43
4. Packer M, O'Connor C, McMurray JJV, Wittes J, Abraham WT, Anker SD et al (2017) Effect of ularitide on cardiovascular mortality in acute heart failure. N Engl J Med 376:1956–1964
5. European Society of Cardiology. Serelaxin fails to meet primary endpoints in phase 3 RELAX-AHF-2 trial.
https://www.escardio.org/The-ESC/Press-Office/Press-releases/serelaxin-fails-to-meet-primary-endpoints-in-phase-3-relax-ahf-2-trial
. Accessed 30 Sep 2018
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献